25 May 2013
Keywords: pfizer, exits, biobypass, deal, genvec, decided, continue
Article | 04 February 2002
Pfizer has decided not to continue its collaboration with GenVec onBioBypass, which is now in Phase II trials for coronary ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 February 2002
24 May 2013
© 2013 thepharmaletter.com